(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLCO1B2 mRNA] CTD PMID:31150632 (S)-naringenin multiple interactions ISO RGD:1350750 6480464 naringenin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein] CTD PMID:22394605 1,2-dichloroethane decreases expression ISO RGD:732053 6480464 ethylene dichloride results in decreased expression of SLCO1B2 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:732053 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLCO1B2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate multiple interactions ISO RGD:732053 6480464 Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA], NFE2L2 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA] CTD PMID:19181614 , PMID:30517764 1-naphthyl isothiocyanate multiple interactions EXP 6480464 dioscin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA], dioscin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 protein] CTD PMID:27317372 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA, 1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 protein CTD PMID:17522070 , PMID:27317372 1-naphthyl isothiocyanate decreases expression ISO RGD:732053 6480464 1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA CTD PMID:19181614 more ... 17alpha-ethynylestradiol multiple interactions ISO RGD:732053 6480464 ESR1 protein promotes the reaction [Ethinyl Estradiol results in decreased expression of SLCO1B2 mRNA], SRT1720 inhibits the reaction [Ethinyl Estradiol results in decreased expression of SLCO1B2 mRNA] CTD PMID:16606610 , PMID:27818225 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of SLCO1B2 protein CTD PMID:12507762 17alpha-ethynylestradiol decreases expression ISO RGD:732053 6480464 Ethinyl Estradiol results in decreased expression of SLCO1B2 mRNA CTD PMID:16606610 , PMID:27818225 17beta-estradiol 17-glucosiduronic acid increases import ISO RGD:1350750 6480464 SLCO1B3 results in increased import of estradiol-17 beta-glucuronide CTD PMID:20176623 17beta-estradiol 17-glucosiduronic acid increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of estradiol-17 beta-glucuronide CTD PMID:32003934 , PMID:32305507 17beta-estradiol 17-glucosiduronic acid multiple interactions ISO RGD:1350750 6480464 2 more ... CTD PMID:18180276 more ... 17beta-estradiol 17-glucosiduronic acid affects response to substance ISO RGD:732053 6480464 SLCO1B2 protein affects the susceptibility to estradiol-17 beta-glucuronide CTD PMID:18296417 17beta-estradiol 17-glucosiduronic acid multiple interactions EXP 6480464 Bile Acids and Salts inhibits the reaction [SLCO1B3 protein results in increased uptake of estradiol-17 beta-glucuronide] CTD PMID:19464309 17beta-estradiol 17-glucosiduronic acid increases uptake EXP 6480464 SLCO1B3 protein results in increased uptake of estradiol-17 beta-glucuronide CTD PMID:19464309 2,2',4,4',5,6'-Hexabromodiphenyl ether increases import ISO RGD:1350750 6480464 SLCO1B3 results in increased import of 2 more ... CTD PMID:20176623 2,2',4,4',5,6'-Hexabromodiphenyl ether multiple interactions ISO RGD:1350750 6480464 2 more ... CTD PMID:20176623 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:1350750 6480464 2 more ... CTD PMID:20176623 2,2',4,4'-Tetrabromodiphenyl ether increases uptake ISO RGD:732053 6480464 SLCO1B2 protein results in increased uptake of 2 more ... CTD PMID:21884716 2,2',4,4'-Tetrabromodiphenyl ether increases import ISO RGD:1350750 6480464 SLCO1B3 results in increased import of 2 more ... CTD PMID:20176623 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732053 6480464 Tetrachlorodibenzodioxin affects the expression of SLCO1B2 mRNA CTD PMID:16611356 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732053 6480464 AHR gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLCO1B2 mRNA] CTD PMID:29452137 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1350750 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of SLCO1B3 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1350750 6480464 Tetrachlorodibenzodioxin affects the expression of SLCO1B3 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1350750 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLCO1B3 mRNA CTD PMID:16837569 , PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732053 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLCO1B2 mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLCO1B3 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLCO1B2 mRNA CTD PMID:22298810 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:732053 6480464 2 more ... CTD PMID:24713691 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of SLCO1B2 mRNA CTD PMID:12044520 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases uptake ISO RGD:732053 6480464 SLCO1B2 protein results in increased uptake of 2 more ... CTD PMID:21884716 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SLCO1B2 mRNA CTD PMID:21346803 2-acetamidofluorene multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of SLCO1B2 mRNA, [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of SLCO1B2 mRNA CTD PMID:14656948 , PMID:16158176 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:732053 6480464 3 more ... CTD PMID:19467301 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:1350750 6480464 tetrabromobisphenol A inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein] CTD PMID:27989701 3,3',5,5'-tetrabromobisphenol A decreases activity ISO RGD:1350750 6480464 tetrabromobisphenol A results in decreased activity of SLCO1B3 protein CTD PMID:27989701 3-methylcholanthrene increases expression ISO RGD:732053 6480464 Methylcholanthrene results in increased expression of SLCO1B2 mRNA CTD PMID:27160211 8-(4-chlorophenylthio)-cAMP increases expression ISO RGD:732053 6480464 8-((4-chlorophenyl)thio)cyclic-3', 5'-AMP results in increased expression of SLCO1B2 mRNA CTD PMID:27160211 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLCO1B2 mRNA CTD PMID:31881176 acetamiprid decreases expression EXP 6480464 acetamiprid results in decreased expression of SLCO1B2 mRNA CTD PMID:27782041 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SLCO1B3 mRNA CTD PMID:28959563 aflatoxin B1 decreases expression ISO RGD:1350750 6480464 Aflatoxin B1 results in decreased expression of SLCO1B3 mRNA CTD PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:1350750 6480464 Aflatoxin B1 results in decreased methylation of SLCO1B3 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:732053 6480464 Aflatoxin B1 results in decreased expression of SLCO1B2 mRNA CTD PMID:19770486 aflatoxin B1 affects expression ISO RGD:1350750 6480464 Aflatoxin B1 affects the expression of SLCO1B3 protein CTD PMID:20106945 allyl alcohol decreases expression ISO RGD:732053 6480464 allyl alcohol results in decreased expression of SLCO1B2 mRNA, allyl alcohol results in decreased expression of SLCO1B2 protein CTD PMID:19371622 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLCO1B3 mRNA CTD PMID:16483693 apigenin multiple interactions ISO RGD:1350750 6480464 Apigenin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein] CTD PMID:22394605 arsane affects methylation ISO RGD:1350750 6480464 Arsenic affects the methylation of SLCO1B3 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1350750 6480464 Arsenic affects the methylation of SLCO1B3 gene CTD PMID:25304211 atorvastatin calcium multiple interactions ISO RGD:1350750 6480464 glimepiride affects the reaction [SLCO1B3 protein results in increased uptake of Atorvastatin] more ... CTD PMID:23121773 , PMID:25106415 atorvastatin calcium increases expression ISO RGD:732053 6480464 Atorvastatin results in increased expression of SLCO1B2 mRNA CTD PMID:25278499 atorvastatin calcium increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Atorvastatin CTD PMID:23121773 , PMID:25106415 benzo[a]pyrene decreases expression ISO RGD:732053 6480464 Benzo(a)pyrene results in decreased expression of SLCO1B2 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO RGD:1350750 6480464 Benzo(a)pyrene results in decreased methylation of SLCO1B3 5' UTR CTD PMID:27901495 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:732053 6480464 Diethylhexyl Phthalate results in decreased expression of SLCO1B2 mRNA CTD PMID:15919853 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLCO1B3 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:732053 6480464 bisphenol A results in increased expression of SLCO1B2 mRNA CTD PMID:30245210 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLCO1B2 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1350750 6480464 bisphenol A inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein] CTD PMID:27989701 bisphenol F multiple interactions ISO RGD:1350750 6480464 bisphenol F promotes the reaction [SLCO1B3 protein results in increased uptake of Fluorescein] CTD PMID:27989701 bromosulfophthalein increases import ISO RGD:1350750 6480464 SLCO1B3 protein results in increased import of Sulfobromophthalein CTD PMID:22394605 bromosulfophthalein increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Sulfobromophthalein CTD PMID:21430235 , PMID:23121773 bromosulfophthalein multiple interactions ISO RGD:1350750 6480464 Apigenin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein] more ... CTD PMID:17369605 more ... bromosulfophthalein increases response to substance ISO RGD:1350750 6480464 SLCO1B3 protein results in increased susceptibility to Sulfobromophthalein CTD PMID:20171238 bromosulfophthalein affects import ISO RGD:1350750 6480464 SLCO1B3 protein affects the import of Sulfobromophthalein CTD PMID:16046661 budesonide multiple interactions ISO RGD:1350750 6480464 Budesonide inhibits the reaction [SLCO1B3 protein results in increased uptake of Mesalamine], Budesonide inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein] CTD PMID:21430235 buta-1,3-diene decreases expression ISO RGD:732053 6480464 1, 3-butadiene results in decreased expression of SLCO1B2 mRNA CTD PMID:29038090 C60 fullerene affects expression EXP 6480464 fullerene C60 affects the expression of SLCO1B3 mRNA CTD PMID:19167457 calcitriol increases expression ISO RGD:1350750 6480464 Calcitriol results in increased expression of SLCO1B3 mRNA CTD PMID:16002434 carbamazepine increases expression ISO RGD:1350750 6480464 Carbamazepine results in increased expression of SLCO1B3 mRNA CTD PMID:17112801 cefalotin multiple interactions ISO RGD:732053 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of SLCO1B2 mRNA CTD PMID:24657338 chenodeoxycholic acid increases transport ISO RGD:1350750 6480464 SLCO1B3 protein results in increased transport of Chenodeoxycholic Acid CTD PMID:18648741 chenodeoxycholic acid increases expression ISO RGD:732053 6480464 Chenodeoxycholic Acid results in increased expression of SLCO1B2 mRNA CTD PMID:25582706 chenodeoxycholic acid multiple interactions ISO RGD:1350750 6480464 [SLCO1B3 protein results in increased transport of Chenodeoxycholic Acid] which results in increased expression of PTGS2 mRNA CTD PMID:18648741 chenodeoxycholic acid increases expression ISO RGD:1350750 6480464 Chenodeoxycholic Acid results in increased expression of SLCO1B3 mRNA CTD PMID:25055961 , PMID:27174168 cholic acid increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Cholic Acid CTD PMID:16534140 cholic acid increases expression ISO RGD:732053 6480464 Cholic Acid results in increased expression of SLCO1B2 mRNA CTD PMID:25582706 cholic acid increases uptake ISO RGD:732053 6480464 SLCO1B2 protein results in increased uptake of Cholic Acid CTD PMID:20949553 cholic acid increases expression ISO RGD:1350750 6480464 Cholic Acid results in increased expression of SLCO1B3 mRNA CTD PMID:25055961 choline multiple interactions ISO RGD:732053 6480464 [LEP gene mutant form co-treated with Methionine deficiency co-treated with Choline deficiency] results in decreased expression of SLCO1B2 mRNA more ... CTD PMID:18952117 , PMID:24384915 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of SLCO1B2 mRNA, [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of SLCO1B2 protein CTD PMID:24384915 , PMID:24403518 ciprofibrate decreases expression ISO RGD:732053 6480464 ciprofibrate results in decreased expression of SLCO1B2 mRNA CTD PMID:15919853 ciprofloxacin increases expression ISO RGD:732053 6480464 Ciprofloxacin results in increased expression of SLCO1B2 mRNA CTD PMID:24657338 cisplatin multiple interactions ISO RGD:1350750 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SLCO1B3 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1350750 6480464 Cisplatin results in decreased expression of SLCO1B3 mRNA CTD PMID:27392435 clarithromycin multiple interactions ISO RGD:1350750 6480464 Clarithromycin inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein] CTD PMID:21430235 clofibrate decreases expression ISO RGD:732053 6480464 Clofibrate results in decreased expression of SLCO1B2 mRNA CTD PMID:15919853 clofibrate increases expression ISO RGD:732053 6480464 Clofibrate results in increased expression of SLCO1B2 mRNA CTD PMID:28973556 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of SLCO1B2 mRNA CTD PMID:17522070 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLCO1B2 mRNA CTD PMID:17602206 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of SLCO1B2 mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO RGD:1350750 6480464 cobaltous chloride results in decreased expression of SLCO1B3 mRNA CTD PMID:19376846 cyazofamid multiple interactions ISO RGD:1350750 6480464 cyazofamid inhibits the reaction [SLCO1B3 protein results in increased uptake of estrone sulfate] CTD PMID:32003934 cyclosporin A multiple interactions ISO RGD:1350750 6480464 Cyclosporine inhibits the reaction [SLCO1B3 protein results in increased import of cyanoginosin LR] more ... CTD PMID:17369605 more ... dehydroepiandrosterone sulfate multiple interactions ISO RGD:1350750 6480464 Dehydroepiandrosterone Sulfate inhibits the reaction [SLCO1B3 protein results in increased susceptibility to cyanoginosin LR], Dehydroepiandrosterone Sulfate inhibits the reaction [SLCO1B3 protein results in increased susceptibility to Okadaic Acid] CTD PMID:26134461 deoxycholic acid increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Deoxycholic Acid CTD PMID:16534140 deoxycholic acid multiple interactions ISO RGD:1350750 6480464 [SLCO1B3 protein results in increased transport of Deoxycholic Acid] which results in increased expression of PTGS2 mRNA CTD PMID:18648741 deoxycholic acid affects expression ISO RGD:732053 6480464 Deoxycholic Acid affects the expression of SLCO1B2 mRNA CTD PMID:25582706 deoxycholic acid increases expression ISO RGD:1350750 6480464 Deoxycholic Acid results in increased expression of SLCO1B3 mRNA CTD PMID:25055961 deoxycholic acid increases transport ISO RGD:1350750 6480464 SLCO1B3 protein results in increased transport of Deoxycholic Acid CTD PMID:18648741 dexamethasone decreases expression ISO RGD:732053 6480464 Dexamethasone results in decreased expression of SLCO1B2 mRNA CTD PMID:15919853 dexamethasone multiple interactions ISO RGD:732053 6480464 [Dexamethasone co-treated with Ibuprofen] results in increased expression of SLCO1B2 mRNA CTD PMID:29222744 dexamethasone increases expression ISO RGD:732053 6480464 Dexamethasone results in increased expression of SLCO1B2 mRNA CTD PMID:29222744 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of SLCO1B3 mRNA] CTD PMID:20032058 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of SLCO1B3 mRNA CTD PMID:20032058 dioscin increases expression EXP 6480464 dioscin results in increased expression of SLCO1B2 mRNA CTD PMID:27317372 dioscin multiple interactions EXP 6480464 dioscin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA], dioscin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 protein] CTD PMID:27317372 DPDPE affects uptake EXP 6480464 SLCO1B2 protein affects the uptake of Enkephalin, D-Penicillamine (2, 5)- CTD PMID:15528320 emodin multiple interactions ISO RGD:732053 6480464 Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA] CTD PMID:30517764 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLCO1B2 mRNA CTD PMID:29391264 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of SLCO1B2 mRNA CTD PMID:17522070 estrone 3-sulfate multiple interactions ISO RGD:1350750 6480464 cyazofamid inhibits the reaction [SLCO1B3 protein results in increased uptake of estrone sulfate] CTD PMID:32003934 Fexofenadine hydrochloride multiple interactions ISO RGD:1350750 6480464 [SLCO1B3 protein co-treated with ABCC2 protein] results in increased uptake of fexofenadine more ... CTD PMID:18180276 Fexofenadine hydrochloride increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of fexofenadine CTD PMID:18245269 Fexofenadine hydrochloride increases expression ISO RGD:732053 6480464 fexofenadine results in increased expression of SLCO1B2 mRNA CTD PMID:24852568 fluorescein multiple interactions ISO RGD:1350750 6480464 bisphenol A inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein] more ... CTD PMID:27989701 fluorescein increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Fluorescein CTD PMID:27989701 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLCO1B2 mRNA, Flutamide results in decreased expression of SLCO1B3 mRNA CTD PMID:24136188 , PMID:24793618 fluvastatin affects import ISO RGD:1350750 6480464 SLCO1B3 protein affects the import of fluvastatin CTD PMID:16046661 furan decreases expression EXP 6480464 furan results in decreased expression of SLCO1B3 mRNA CTD PMID:25539665 , PMID:26194646 fusidic acid multiple interactions ISO RGD:1350750 6480464 Fusidic Acid inhibits the reaction [SLCO1B3 protein results in increased uptake of Rosuvastatin Calcium] CTD PMID:26888941 fusidic acid multiple interactions EXP 6480464 Fusidic Acid inhibits the reaction [SLCO1B2 protein results in increased uptake of Rosuvastatin Calcium] CTD PMID:26888941 fusidic acid decreases activity ISO RGD:1350750 6480464 Fusidic Acid results in decreased activity of SLCO1B3 protein CTD PMID:27676153 ginsenoside Rb1 multiple interactions ISO RGD:1350750 6480464 ginsenoside Rb1 binds to and results in decreased activity of SLCO1B3 protein CTD PMID:25297453 ginsenoside Rc multiple interactions ISO RGD:1350750 6480464 ginsenoside Rc binds to and results in decreased activity of SLCO1B3 protein CTD PMID:25297453 ginsenoside Rd multiple interactions ISO RGD:1350750 6480464 ginsenoside Rd binds to and results in decreased activity of SLCO1B3 protein CTD PMID:25297453 ginsenoside Re multiple interactions ISO RGD:1350750 6480464 SLCO1B3 protein binds to and results in increased transport of ginsenoside Re CTD PMID:25297453 ginsenoside Re multiple interactions EXP 6480464 SLCO1B2 protein binds to and results in increased transport of ginsenoside Re CTD PMID:25297453 ginsenoside Rg1 multiple interactions ISO RGD:1350750 6480464 SLCO1B3 protein binds to and results in increased transport of ginsenoside Rg1 CTD PMID:25297453 ginsenoside Rg1 multiple interactions EXP 6480464 SLCO1B2 protein binds to and results in increased transport of ginsenoside Rg1 CTD PMID:25297453 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of SLCO1B2 mRNA CTD PMID:24136188 glimepiride multiple interactions ISO RGD:1350750 6480464 glimepiride affects the reaction [SLCO1B3 protein results in increased uptake of Atorvastatin], glimepiride affects the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein] CTD PMID:23121773 glyburide multiple interactions ISO RGD:1350750 6480464 Glyburide inhibits the reaction [SLCO1B3 protein results in increased uptake of Atorvastatin] CTD PMID:23121773 GW 4064 increases expression ISO RGD:732053 6480464 GW 4064 results in increased expression of SLCO1B2 mRNA CTD PMID:27609522 hydroxyurea increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Hydroxyurea CTD PMID:21256917 hydroxyurea multiple interactions ISO RGD:1350750 6480464 naringin inhibits the reaction [SLCO1B3 protein results in increased uptake of Hydroxyurea], Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of Hydroxyurea] CTD PMID:21256917 ibuprofen multiple interactions ISO RGD:732053 6480464 [Dexamethasone co-treated with Ibuprofen] results in increased expression of SLCO1B2 mRNA CTD PMID:29222744 icariin multiple interactions ISO RGD:1350750 6480464 [icariin results in decreased activity of SLCO1B3 protein] which results in decreased uptake of Sincalide CTD PMID:24265111 icariin decreases activity ISO RGD:1350750 6480464 icariin results in decreased activity of SLCO1B3 protein CTD PMID:24265111 imipenem hydrate multiple interactions ISO RGD:732053 6480464 [Vancomycin co-treated with Imipenem] results in increased expression of SLCO1B2 mRNA CTD PMID:24657338 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of SLCO1B2 mRNA, Indomethacin results in decreased expression of SLCO1B2 protein CTD PMID:17329856 indoxyl sulfate decreases expression ISO RGD:1350750 6480464 Indican results in decreased expression of SLCO1B3 mRNA CTD PMID:30639138 kaempferol multiple interactions ISO RGD:1350750 6480464 kaempferol inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein] CTD PMID:22394605 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of SLCO1B2 mRNA, [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of SLCO1B2 protein CTD PMID:24384915 , PMID:24403518 L-methionine multiple interactions ISO RGD:732053 6480464 [LEP gene mutant form co-treated with Methionine deficiency co-treated with Choline deficiency] results in decreased expression of SLCO1B2 mRNA more ... CTD PMID:18952117 , PMID:24384915 lead diacetate decreases expression ISO RGD:732053 6480464 lead acetate results in decreased expression of SLCO1B2 mRNA CTD PMID:22609695 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of SLCO1B2 mRNA CTD PMID:15205389 lipopolysaccharide decreases expression ISO RGD:732053 6480464 Lipopolysaccharides results in decreased expression of SLCO1B2 mRNA CTD PMID:30633930 lipopolysaccharide multiple interactions ISO RGD:732053 6480464 Lipopolysaccharides promotes the reaction [triptolide results in decreased expression of SLCO1B2 mRNA], triptolide promotes the reaction [Lipopolysaccharides results in decreased expression of SLCO1B2 mRNA] CTD PMID:30633930 lithocholic acid increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Lithocholic Acid CTD PMID:16534140 lithocholic acid multiple interactions ISO RGD:1350750 6480464 [SLCO1B3 protein results in increased transport of Lithocholic Acid] which results in increased expression of PTGS2 mRNA CTD PMID:18648741 lithocholic acid increases expression ISO RGD:732053 6480464 Lithocholic Acid results in increased expression of SLCO1B2 mRNA CTD PMID:25582706 lithocholic acid multiple interactions ISO RGD:732053 6480464 Lithocholic Acid inhibits the reaction [NR1H3 protein results in increased expression of SLCO1B2 mRNA] CTD PMID:17256725 lithocholic acid decreases expression ISO RGD:732053 6480464 Lithocholic Acid results in decreased expression of SLCO1B2 mRNA CTD PMID:12637555 , PMID:17256725 lithocholic acid increases transport ISO RGD:1350750 6480464 SLCO1B3 protein results in increased transport of Lithocholic Acid CTD PMID:18648741 lithocholic acid increases expression ISO RGD:1350750 6480464 Lithocholic Acid results in increased expression of SLCO1B3 mRNA CTD PMID:25055961 mesalamine multiple interactions ISO RGD:1350750 6480464 Budesonide inhibits the reaction [SLCO1B3 protein results in increased uptake of Mesalamine] more ... CTD PMID:21430235 mesalamine increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Mesalamine CTD PMID:21430235 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SLCO1B2 mRNA CTD PMID:28529062 microcystin increases response to substance ISO RGD:1350750 6480464 SLCO1B3 protein results in increased susceptibility to microcystin analog CTD PMID:20171238 microcystin increases uptake ISO RGD:732053 6480464 SLCO1B2 protein results in increased uptake of Microcystins CTD PMID:20472527 microcystin increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Microcystins CTD PMID:20472527 microcystin LF increases response to substance ISO RGD:1350750 6480464 SLCO1B3 protein results in increased susceptibility to microcystin-LF CTD PMID:20171238 microcystin-LR increases import ISO RGD:1350750 6480464 SLCO1B3 protein results in increased import of cyanoginosin LR CTD PMID:17369605 microcystin-LR multiple interactions ISO RGD:1350750 6480464 Cyclosporine inhibits the reaction [SLCO1B3 protein results in increased import of cyanoginosin LR] more ... CTD PMID:17369605 more ... microcystin-LR increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of cyanoginosin LR CTD PMID:25456266 , PMID:26134461 microcystin-LR affects response to substance ISO RGD:732053 6480464 SLCO1B2 protein affects the susceptibility to cyanoginosin LR CTD PMID:18296417 microcystin-LR increases response to substance ISO RGD:732053 6480464 SLCO1B2 results in increased susceptibility to cyanoginosin LR CTD PMID:19027771 microcystin-LR decreases expression ISO RGD:732053 6480464 cyanoginosin LR results in decreased expression of SLCO1B2 mRNA CTD PMID:17654400 microcystin-LR increases response to substance ISO RGD:1350750 6480464 SLCO1B3 protein results in increased susceptibility to cyanoginosin LR CTD PMID:17369605 more ... N-nitrosodiethylamine decreases expression ISO RGD:732053 6480464 Diethylnitrosamine results in decreased expression of SLCO1B2 mRNA, Diethylnitrosamine results in decreased expression of SLCO1B2 protein CTD PMID:25319454 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of SLCO1B2 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of SLCO1B2 mRNA more ... CTD PMID:14656948 more ... naringin multiple interactions ISO RGD:1350750 6480464 naringin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein], naringin inhibits the reaction [SLCO1B3 protein results in increased uptake of Hydroxyurea] CTD PMID:21256917 , PMID:22394605 nateglinide multiple interactions ISO RGD:1350750 6480464 Nateglinide inhibits the reaction [SLCO1B3 protein results in increased uptake of Atorvastatin], Nateglinide inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein] CTD PMID:23121773 neomycin multiple interactions ISO RGD:732053 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of SLCO1B2 mRNA CTD PMID:24657338 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of SLCO1B2 mRNA CTD PMID:24136188 notoginsenoside R1 multiple interactions ISO RGD:1350750 6480464 SLCO1B3 protein binds to and results in increased transport of notoginsenoside R1 CTD PMID:25297453 notoginsenoside R1 multiple interactions EXP 6480464 SLCO1B2 protein binds to and results in increased transport of notoginsenoside R1 CTD PMID:25297453 obeticholic acid increases expression ISO RGD:1350750 6480464 obeticholic acid results in increased expression of SLCO1B3 mRNA CTD PMID:27939613 obeticholic acid increases expression EXP 6480464 obeticholic acid results in increased expression of SLCO1B2 mRNA CTD PMID:27255380 obeticholic acid multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLCO1B2 mRNA] CTD PMID:27255380 ochratoxin A increases transport ISO RGD:732053 6480464 SLCO1B2 protein results in increased transport of ochratoxin A CTD PMID:32470353 ochratoxin A increases transport ISO RGD:1350750 6480464 SLCO1B3 protein results in increased transport of ochratoxin A CTD PMID:32470353 okadaic acid multiple interactions ISO RGD:1350750 6480464 Dehydroepiandrosterone Sulfate inhibits the reaction [SLCO1B3 protein results in increased susceptibility to Okadaic Acid] more ... CTD PMID:26134461 okadaic acid increases response to substance ISO RGD:1350750 6480464 SLCO1B3 protein results in increased susceptibility to Okadaic Acid CTD PMID:26134461 oleanolic acid decreases expression ISO RGD:732053 6480464 Oleanolic Acid results in decreased expression of SLCO1B2 protein CTD PMID:23948738 oleanolic acid multiple interactions ISO RGD:732053 6480464 Oleanolic Acid inhibits the reaction [Phalloidine results in increased expression of SLCO1B2 mRNA] CTD PMID:25280775 oltipraz decreases expression ISO RGD:1350750 6480464 oltipraz results in decreased expression of SLCO1B3 mRNA CTD PMID:16837569 oroxylin A increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of 5, 7-dihydroxy-6-methoxy-2-phenylchromen-4-one CTD PMID:32305507 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of SLCO1B2 mRNA CTD PMID:23439660 paracetamol affects expression ISO RGD:732053 6480464 Acetaminophen affects the expression of SLCO1B2 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:732053 6480464 [Acetaminophen co-treated with Sodium Chloride] results in decreased expression of SLCO1B2 mRNA CTD PMID:17934960 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLCO1B2 mRNA CTD PMID:17522070 pentachlorophenol decreases expression ISO RGD:732053 6480464 Pentachlorophenol results in decreased expression of SLCO1B2 mRNA CTD PMID:23892564 perfluorobutanesulfonic acid increases transport ISO RGD:1350750 6480464 SLCO1B3 protein results in increased transport of perfluorobutanesulfonic acid CTD PMID:28013215 perfluorobutanesulfonic acid increases transport EXP 6480464 SLCO1B2 protein results in increased transport of perfluorobutanesulfonic acid CTD PMID:28013215 perfluorodecanoic acid decreases expression ISO RGD:732053 6480464 perfluorodecanoic acid results in decreased expression of SLCO1B2 mRNA, perfluorodecanoic acid results in decreased expression of SLCO1B2 protein CTD PMID:18703564 , PMID:27344344 perfluorodecanoic acid multiple interactions ISO RGD:732053 6480464 PPARA protein affects the reaction [perfluorodecanoic acid results in decreased expression of SLCO1B2 mRNA] CTD PMID:18703564 , PMID:27344344 perfluorohexanesulfonic acid increases transport ISO RGD:1350750 6480464 SLCO1B3 protein results in increased transport of perfluorohexanesulfonic acid CTD PMID:28013215 perfluorohexanesulfonic acid increases transport EXP 6480464 SLCO1B2 protein results in increased transport of perfluorohexanesulfonic acid CTD PMID:28013215 perfluorononanoic acid decreases expression ISO RGD:732053 6480464 perfluorononanoic acid results in decreased expression of SLCO1B2 mRNA CTD PMID:29112762 perfluorooctane-1-sulfonic acid increases transport ISO RGD:1350750 6480464 SLCO1B3 protein results in increased transport of perfluorooctane sulfonic acid CTD PMID:28013215 perfluorooctane-1-sulfonic acid increases transport EXP 6480464 SLCO1B2 protein results in increased transport of perfluorooctane sulfonic acid CTD PMID:28013215 perfluorooctanoic acid affects expression ISO RGD:732053 6480464 perfluorooctanoic acid affects the expression of SLCO1B2 mRNA CTD PMID:18281256 perfluorooctanoic acid decreases expression ISO RGD:732053 6480464 perfluorooctanoic acid results in decreased expression of SLCO1B2 mRNA, perfluorooctanoic acid results in decreased expression of SLCO1B2 protein CTD PMID:18703564 phalloidin affects response to substance ISO RGD:732053 6480464 SLCO1B2 protein affects the susceptibility to Phalloidine CTD PMID:18296417 phalloidin increases uptake ISO RGD:732053 6480464 SLCO1B2 protein results in increased uptake of Phalloidine CTD PMID:25280775 phalloidin increases expression ISO RGD:732053 6480464 Phalloidine results in increased expression of SLCO1B2 mRNA CTD PMID:25280775 phalloidin multiple interactions ISO RGD:732053 6480464 [KEAP1 gene mutant form results in decreased susceptibility to Phalloidine] which results in increased expression of SLCO1B2 mRNA more ... CTD PMID:25280775 phalloidin increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Phalloidine CTD PMID:19464309 , PMID:25280775 phenobarbital increases expression ISO RGD:732053 6480464 Phenobarbital results in increased expression of SLCO1B2 mRNA CTD PMID:27160211 phenobarbital decreases expression ISO RGD:732053 6480464 Phenobarbital results in decreased expression of SLCO1B2 mRNA CTD PMID:23091169 phenobarbital decreases expression ISO RGD:1350750 6480464 Phenobarbital results in decreased expression of SLCO1B3 mRNA CTD PMID:16837569 pioglitazone multiple interactions ISO RGD:1350750 6480464 pioglitazone affects the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein] CTD PMID:23121773 pirinixic acid multiple interactions ISO RGD:732053 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of SLCO1B2 mRNA CTD PMID:20813756 pirinixic acid decreases expression ISO RGD:732053 6480464 pirinixic acid results in decreased expression of SLCO1B2 mRNA CTD PMID:18445702 , PMID:20813756 potassium dichromate increases expression ISO RGD:732053 6480464 Potassium Dichromate results in increased expression of SLCO1B2 mRNA CTD PMID:23608068 pravastatin multiple interactions ISO RGD:1350750 6480464 Pravastatin inhibits the reaction [SLCO1B3 protein results in increased uptake of Mesalamine], Pravastatin inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein] CTD PMID:21430235 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:732053 6480464 Pregnenolone Carbonitrile results in decreased expression of SLCO1B2 mRNA CTD PMID:15919853 probenecid multiple interactions ISO RGD:1350750 6480464 Probenecid inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein] CTD PMID:27989701 pyrazinecarboxamide decreases expression EXP 6480464 Pyrazinamide results in decreased expression of SLCO1B2 mRNA, Pyrazinamide results in decreased expression of SLCO1B2 protein CTD PMID:27255380 pyrazinecarboxamide multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLCO1B2 mRNA] CTD PMID:27255380 quercetin multiple interactions ISO RGD:1350750 6480464 Quercetin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein] CTD PMID:22394605 quercetin increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Quercetin CTD PMID:24947867 Repaglinide multiple interactions ISO RGD:1350750 6480464 repaglinide inhibits the reaction [SLCO1B3 protein results in increased uptake of Atorvastatin] CTD PMID:23121773 rifampicin multiple interactions ISO RGD:1350750 6480464 Rifampin inhibits the reaction [SLCO1B3 protein results in increased import of cyanoginosin LR] more ... CTD PMID:17369605 more ... rifampicin decreases activity ISO RGD:1350750 6480464 Rifampin results in decreased activity of SLCO1B3 protein CTD PMID:31830554 , PMID:32305507 rifampicin decreases expression ISO RGD:1350750 6480464 Rifampin results in decreased expression of SLCO1B3 mRNA CTD PMID:27199754 rifamycin SV decreases activity ISO RGD:1350750 6480464 rifamycin SV results in decreased activity of SLCO1B3 protein CTD PMID:31364238 rifamycin SV multiple interactions ISO RGD:1350750 6480464 rifamycin SV inhibits the reaction [SLCO1B3 protein results in increased import of 8-sulfocholecystokinin octapeptide] CTD PMID:27450509 rosuvastatin calcium increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Rosuvastatin Calcium CTD PMID:26888941 , PMID:31299240 rosuvastatin calcium increases uptake EXP 6480464 SLCO1B2 protein results in increased uptake of Rosuvastatin Calcium CTD PMID:26888941 rosuvastatin calcium multiple interactions EXP 6480464 Fusidic Acid inhibits the reaction [SLCO1B2 protein results in increased uptake of Rosuvastatin Calcium] CTD PMID:26888941 rosuvastatin calcium multiple interactions ISO RGD:1350750 6480464 Fusidic Acid inhibits the reaction [SLCO1B3 protein results in increased uptake of Rosuvastatin Calcium] CTD PMID:26888941 rutin multiple interactions ISO RGD:1350750 6480464 Rutin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein] CTD PMID:22394605 senecionine decreases expression ISO RGD:1350750 6480464 senecionine results in decreased expression of SLCO1B3 mRNA CTD PMID:26100227 senecionine decreases expression ISO RGD:732053 6480464 senecionine results in decreased expression of SLCO1B2 mRNA CTD PMID:31606820 senecionine decreases expression EXP 6480464 senecionine results in decreased expression of SLCO1B2 mRNA CTD PMID:24641316 sincalide multiple interactions ISO RGD:1350750 6480464 [icariin results in decreased activity of SLCO1B3 protein] which results in decreased uptake of Sincalide CTD PMID:24265111 sincalide affects uptake ISO RGD:1350750 6480464 SLCO1B3 protein affects the uptake of Sincalide CTD PMID:15665139 sincalide affects import ISO RGD:1350750 6480464 SLCO1B3 protein affects the import of Sincalide CTD PMID:16046661 sodium arsenite multiple interactions ISO RGD:732053 6480464 [Dietary Fats co-treated with sodium arsenite] results in decreased expression of SLCO1B2 mRNA, sodium arsenite promotes the reaction [soybean oil, phospholipid emulsion results in increased expression of SLCO1B2 mRNA] CTD PMID:26890134 sodium arsenite decreases expression ISO RGD:732053 6480464 sodium arsenite results in decreased expression of SLCO1B2 mRNA CTD PMID:17350061 , PMID:26890134 sodium chloride multiple interactions ISO RGD:732053 6480464 [Acetaminophen co-treated with Sodium Chloride] results in decreased expression of SLCO1B2 mRNA CTD PMID:17934960 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of SLCO1B2 mRNA CTD PMID:25993096 spironolactone decreases expression ISO RGD:732053 6480464 Spironolactone results in decreased expression of SLCO1B2 mRNA CTD PMID:15919853 taurocholic acid multiple interactions ISO RGD:1350750 6480464 Taurocholic Acid inhibits the reaction [SLCO1B3 protein results in increased susceptibility to cyanoginosin LR], Taurocholic Acid inhibits the reaction [SLCO1B3 protein results in increased susceptibility to Okadaic Acid] CTD PMID:26134461 taurocholic acid increases expression ISO RGD:732053 6480464 Taurocholic Acid results in increased expression of SLCO1B2 mRNA CTD PMID:27160211 taurocholic acid increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Taurocholic Acid CTD PMID:19464309 , PMID:30639138 taurocholic acid increases uptake EXP 6480464 SLCO1B3 protein results in increased uptake of Taurocholic Acid CTD PMID:19464309 taurocholic acid multiple interactions EXP 6480464 Bile Acids and Salts inhibits the reaction [SLCO1B3 protein results in increased uptake of Taurocholic Acid] CTD PMID:19464309 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of SLCO1B3 mRNA] CTD PMID:20032058 testosterone decreases expression ISO RGD:732053 6480464 Testosterone results in decreased expression of SLCO1B2 mRNA CTD PMID:21669218 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLCO1B2 mRNA CTD PMID:17522070 , PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLCO1B2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:732053 6480464 Carbon Tetrachloride results in decreased expression of SLCO1B2 mRNA CTD PMID:27339419 , PMID:31919559 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of SLCO1B2 mRNA CTD PMID:17522070 theophylline increases expression EXP 6480464 Theophylline results in increased expression of SLCO1B2 mRNA CTD PMID:17522070 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLCO1B2 mRNA more ... CTD PMID:23411599 , PMID:26222700 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SLCO1B2 mRNA CTD PMID:28943392 titanium dioxide affects expression ISO RGD:732053 6480464 titanium dioxide affects the expression of SLCO1B2 mRNA CTD PMID:23557971 Triptolide multiple interactions ISO RGD:732053 6480464 Lipopolysaccharides promotes the reaction [triptolide results in decreased expression of SLCO1B2 mRNA], triptolide promotes the reaction [Lipopolysaccharides results in decreased expression of SLCO1B2 mRNA] CTD PMID:30633930 Triptolide decreases expression ISO RGD:732053 6480464 triptolide results in decreased expression of SLCO1B2 mRNA CTD PMID:30633930 trospium chloride decreases activity ISO RGD:1350750 6480464 trospium chloride results in decreased activity of SLCO1B3 protein CTD PMID:25466967 trovafloxacin multiple interactions ISO RGD:732053 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SLCO1B3 mRNA CTD PMID:18930950 ursodeoxycholic acid increases uptake ISO RGD:1350750 6480464 SLCO1B3 protein results in increased uptake of Ursodeoxycholic Acid, SLCO1B3 protein results in increased uptake of Ursodeoxycholic Acid metabolite CTD PMID:16534140 , PMID:31299240 ursodeoxycholic acid multiple interactions ISO RGD:1350750 6480464 Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of Ursodeoxycholic Acid metabolite] CTD PMID:31299240 ursodeoxycholic acid increases expression ISO RGD:732053 6480464 Ursodeoxycholic Acid results in increased expression of SLCO1B2 mRNA CTD PMID:25582706 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of SLCO1B3 mRNA CTD PMID:15885361 valproic acid decreases expression ISO RGD:1350750 6480464 Valproic Acid results in decreased expression of SLCO1B3 mRNA CTD PMID:29154799 valproic acid increases expression ISO RGD:732053 6480464 Valproic Acid results in increased expression of SLCO1B2 mRNA CTD PMID:27160211 vancomycin multiple interactions ISO RGD:732053 6480464 [Vancomycin co-treated with Imipenem] results in increased expression of SLCO1B2 mRNA CTD PMID:24657338 warfarin affects response to substance ISO RGD:1350750 6480464 SLCO1B3 gene SNP affects the susceptibility to Warfarin CTD PMID:29234073
Gene-Chemical Interaction Annotations
